NASDAQ
Annovis Bio, Inc. (ANVS) has a free cash flow growth of -0.95% as of Friday, June 12, 2026. This represents a 95.54% increase compared to its 12-month average of -21.27%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.